In hepatitis B surface antigen (HBsAg) transgenic mice, TIGIT blockade leads to emergence of HBsAg-specific T cells, chronic hepatitis and progression to HCC, suggesting a role for TIGIT in maintaining immune tolerance to HBsAg in this model (141). This evidence concerns the gene TIGIT and hepatocellular carcinoma.